Stock 4009 MIDDLE EAST HEALTHCARE COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Middle East Healthcare Company

Equities

4009

SA141H01UKH9

End-of-day quote Saudi Arabian S.E.
Other stock markets
 06:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
91 SAR +1.11% Intraday chart for Middle East Healthcare Company -0.11% +3.06%
Apr. 04 Middle East Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 31 Middle East Healthcare Co. Reports Higher FY23 Profit, Revenue MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • One of the major weak points of the company is its financial situation.
  • With an expected P/E ratio at 32.41 and 23.93 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • With an enterprise value anticipated at 3.56 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
MIDDLE EAST HEALTHCARE COMPANY Stock Middle East Healthcare Company
+3.06% 2.23B -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-18.46% 16.57B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.51B
B
IHH HEALTHCARE Stock IHH Healthcare
+4.31% 11.69B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+5.36% 10.36B
B+
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+24.72% 8.38B
B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.64% 7.75B
A-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.04% 7.16B
D
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.17% 6.6B
B-
GLOBAL HEALTH LIMITED Stock Global Health Limited
+46.90% 4.54B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4009 Stock
  4. Ratings Middle East Healthcare Company